Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/1999
06/17/1999WO1999029732A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/17/1999WO1999029731A1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
06/17/1999WO1999029723A1 Recombinant nodavirus compositions and methods
06/17/1999WO1999029695A1 Novel compounds
06/17/1999WO1999029694A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
06/17/1999WO1999029693A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
06/17/1999WO1999029686A1 Novel compounds
06/17/1999WO1999029661A1 Adamantane derivatives
06/17/1999WO1999029660A1 Adamantane derivatives
06/17/1999WO1999029344A1 Product and process for targeting an immune response
06/17/1999WO1999029340A1 An over-expressing homologous antigen vaccine and a method of making the same
06/17/1999WO1999029339A2 Prevention and/or treatment of allergic conditions
06/17/1999WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
06/17/1999WO1999029182A1 Method for purifying heat shock peptides complexes
06/17/1999WO1999017801A3 Materials and methods relating to the stimulation of cells
06/17/1999WO1999017787A3 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
06/17/1999WO1999009162A3 Delayed progression to aids by a missense allele of the ccr2 gene
06/17/1999WO1998056919A3 Methods and reagents for vaccination which generate a cd8 t cell immune response
06/17/1999WO1998018823A8 Ice inhibiting peptides
06/17/1999DE19755800A1 Cyclopeptidderivate Cyclopeptide derivatives
06/17/1999CA2693296A1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/17/1999CA2317806A1 An over-expressing homologous antigen vaccine and a method of making the same
06/17/1999CA2313451A1 Cyclic gmp phosphodiesterase
06/17/1999CA2313450A1 G-protein coupled receptors associated with immune response
06/17/1999CA2313150A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
06/17/1999CA2312889A1 Adamantane derivatives
06/17/1999CA2312420A1 Adamantane derivatives
06/17/1999CA2312419A1 Novel compounds
06/17/1999CA2312357A1 Novel compounds
06/17/1999CA2312049A1 Method for purifying heat shock peptides complexes
06/17/1999CA2311681A1 Human interferon-epsilon: a type i interferon
06/16/1999EP0922111A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways
06/16/1999EP0922100A2 Secreted proteins and polynucleotides encoding them
06/16/1999EP0922036A1 Arylalkanoyl pyridazines
06/16/1999EP0921816A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
06/16/1999EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin
06/16/1999EP0921810A2 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity
06/16/1999EP0921809A1 Use of prolactin as a tgf-beta antagonist
06/16/1999EP0827507B1 Protease inhibiting succinic acid derivatives
06/16/1999EP0804411A4 Synthetic polyunsaturated fatty acid analogues
06/16/1999CN1219936A New triazolopurines, method of preparing them and their use as drugs
06/16/1999CN1219934A Novel pyridazine compounds
06/16/1999CN1219929A Urea derivatives as inhibitors of IMPDH enzyme
06/16/1999CN1219928A Novel vitamin D analogues
06/16/1999CN1219882A Concentrated antibody preparation
06/16/1999CN1219881A Caprine arthritis-encephalitis virus provides immunoprotection against HIV-1 infection
06/16/1999CN1043641C Hydroisoquinoline derivatives
06/16/1999CN1043640C Process for preparing oxazolyl derivatives
06/16/1999CN1043639C New piperidine compounds, process for their preparation and pharmaceutical compositions which contain them
06/15/1999US5912360 Dioxolane intermediates
06/15/1999US5912348 Isomerization promoted with bases
06/15/1999US5912270 Anti-inflammatory compounds
06/15/1999US5912253 Rapamycin derivatives
06/15/1999US5912176 Antibodies against a host cell antigen complex for pre and post exposure protection from infection by HIV
06/15/1999US5912005 Methods of use of uncoated gel particles
06/10/1999WO1999028748A2 Hla-e binding
06/10/1999WO1999028493A2 Method for identifying inhibitors of g-protein coupled receptor hibef51
06/10/1999WO1999028473A1 A cDNA ENCODING C6 β-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN
06/10/1999WO1999028472A1 A cDNA ENCODING C6 β-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN
06/10/1999WO1999028349A2 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS
06/10/1999WO1999028320A1 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
06/10/1999WO1999028310A1 Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride
06/10/1999WO1999027963A1 Antibody production methods relating to disruption of peripheral tolerance in b lymphocytes
06/10/1999WO1999027961A1 Transdermal delivery of particulate vaccine compositions
06/10/1999WO1999027960A1 Vaccine compositions for mucosal administration comprising chitosan
06/10/1999WO1999027959A1 Saponin adjuvant composition
06/10/1999WO1999027958A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/10/1999WO1999027957A1 Vaccination and methods against multiple sclerosis using specific tcr vbeta peptides
06/10/1999WO1999027956A1 Tolerance inducing combination of at least two endogenous antigens for treatment of sms, sle, iddm, etc.
06/10/1999WO1999027954A2 Mixed lipopeptide micelles for inducing an immune response
06/10/1999WO1999027948A2 Use of soluble recombinant human cd40l protein for inhibiting in vivo immune response
06/10/1999WO1999027935A1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
06/10/1999WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
06/10/1999WO1999013095A3 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
06/10/1999WO1999010375A3 Vaccine against hpv
06/10/1999WO1999005175A3 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1)
06/10/1999WO1998004582A8 Isolated peptides derived from mage-2
06/10/1999CA2312900A1 Transdermal delivery of particulate vaccine compositions
06/10/1999CA2312043A1 Mixed lipopeptide micelles for inducing an immune response
06/10/1999CA2311892A1 Saponin adjuvant composition
06/10/1999CA2311647A1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/10/1999CA2311574A1 Cells expressing anti-fc receptor binding components
06/10/1999CA2310718A1 Vaccine compositions for mucosal administration comprising chitosan
06/09/1999EP0921197A2 Human disintegrin metalloprotease related to drosophila kuz gene
06/09/1999EP0921121A1 Intermediates to therapeutic nucleosides
06/09/1999EP0921114A1 Intermediates to therapeutic nucleosides
06/09/1999EP0920867A1 Pyrido[2,3-a]pyrazine derivatives as PDE-IV and TNF inhibitors
06/09/1999EP0920865A1 Pharmaceutical compositions containing Norastemizole
06/09/1999EP0920632A1 Materials and methods for detection and treatment of immune system dysfunctions
06/09/1999EP0920630A2 Prion protein binding proteins and uses thereof
06/09/1999EP0920512A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
06/09/1999EP0920507A2 Secreted proteins and polynucleotides encoding them
06/09/1999EP0920505A1 Mammalian cell surface antigens; related reagents
06/09/1999EP0920499A2 Polynucleotides encoding secreted proteins
06/09/1999EP0920451A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
06/09/1999EP0920447A1 Process of purification of cyclosporin
06/09/1999EP0920444A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
06/09/1999EP0920428A1 Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
06/09/1999EP0920425A1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
06/09/1999EP0920335A1 Use of proteolytic enzymes for preventing or treating graft rejection
1 ... 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 ... 1172